Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans
Data up to Jan 2025
Total Citations Per Year
Abstract
References (13)
The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
1992 • 321 citations
Pharmacokinetics of Citalopram in Relation to the Sparteine and the Mephenytoin Oxidation Polymorphisms
1993 • 214 citations
Racemization, enantiomerization, diastereomerization, and epimerization: Their meaning and pharmacological significance
1995 • 151 citations
Analysis of Enantiomers of Citalopram and Its Demethylated Metabolites in Plasma of Depressive Patients Using Chiral Reverse-Phase Liquid Chromatography
1995 • 126 citations
Identification of cytochrome P450 isoforms involved in citalopram N-demethylation by human liver microsomes.
1997 • 126 citations
SEROTONIN‐SELECTIVE ANTIDEPRESSANTS.
1985 • 83 citations
Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans. Studies with anionic, cationic and zwitterionic drugs.
1986 • 82 citations
Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC
1995 • 72 citations
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation
1996 • 67 citations
High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients
1984 • 67 citations
The Effect of Age and Concomitant Treatment with Other Psychoactive Drugs on Serum Concentrations of Citalopram Measured with a Nonenantioselective Method
1996 • 38 citations
Computation of Model-Independent Pharmacokinetic Parameters During Multiple Dosing
1984 • 20 citations
Molecular Asymmetry and Its Pharmacological Consequences
1991 • 12 citations